You are currently viewing a new version of our website. To view the old version click .
Hematology Reports
  • Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
  • Case Report
  • Open Access

3 April 2018

Neurofibromatosis Type I and Multiple Myeloma Coexistence: A Possible Link?

,
,
,
,
,
,
,
,
and
1
Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy
2
Hematology Unit, Parma University Hospital, 43126 Parma, Italy
3
Pathology Unit, Parma University Hospital, 43126 Parma, Italy
4
Pediatric Orthopedics, Rizzoli Orthopedic Institute, 40121 Bologna, Italy

Abstract

The association between Neurofibromatosis type I (NF1) and multiple myeloma (MM), a plasma cell, dyscrasia is very rare. Here we put to the attention of the scientific community two new cases. The first one is a patient with active MM whereas the second with smoldering MM. Both patients present typical features of NF1 but skeletal alterations were present only in the second case including dysplasia, marked scoliosis and osteoporosis. MM osteolytic lesions were absent in both patients. In addition to the clinical diagnosis of NF1, a molecular testing for NF1 gene mutations has been performed finding that patient one was heterozygous for the c.6855C>A (Tyr2285Ter) mutation, while patient two was heterozygous for the c.7838dupC (Lys2614GlufsTer20) mutation. The two mutations were diagnosed both in genomic DNA from peripheral blood and from MM cells. The potential link between NF1 mutation and the increased risk of MM is discussed in the report.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.